CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 260 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,540,778 | -2.0% | 102,588 | +23.7% | 0.00% | 0.0% |
| Q1 2024 | $5,651,146 | +34.6% | 82,910 | +23.6% | 0.00% | 0.0% |
| Q4 2023 | $4,198,144 | +37.7% | 67,063 | -0.1% | 0.00% | 0.0% |
| Q3 2023 | $3,047,939 | -15.7% | 67,150 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $3,617,382 | +30.9% | 64,435 | +5.5% | 0.00% | 0.0% |
| Q1 2023 | $2,763,282 | +23.5% | 61,094 | +11.0% | 0.00% | 0.0% |
| Q4 2022 | $2,237,985 | -37.1% | 55,055 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $3,557,000 | +5.8% | 54,436 | -1.6% | 0.00% | 0.0% |
| Q2 2022 | $3,361,000 | +1.7% | 55,306 | +5.0% | 0.00% | 0.0% |
| Q1 2022 | $3,306,000 | -16.1% | 52,677 | +1.3% | 0.00% | 0.0% |
| Q4 2021 | $3,940,000 | -26.2% | 52,002 | +9.0% | 0.00% | -50.0% |
| Q3 2021 | $5,338,000 | -7.8% | 47,691 | +33.3% | 0.00% | 0.0% |
| Q2 2021 | $5,790,000 | +43.0% | 35,765 | +7.6% | 0.00% | 0.0% |
| Q1 2021 | $4,050,000 | -10.0% | 33,235 | +13.1% | 0.00% | 0.0% |
| Q4 2020 | $4,499,000 | +75.7% | 29,381 | -4.0% | 0.00% | +100.0% |
| Q3 2020 | $2,560,000 | +32.1% | 30,599 | +16.0% | 0.00% | 0.0% |
| Q2 2020 | $1,938,000 | +352.8% | 26,378 | +190.6% | 0.00% | – |
| Q1 2020 | $428,000 | -79.2% | 9,077 | -73.2% | 0.00% | -100.0% |
| Q4 2019 | $2,060,000 | +4581.8% | 33,830 | +3018.0% | 0.00% | – |
| Q3 2019 | $44,000 | -13.7% | 1,085 | 0.0% | 0.00% | – |
| Q2 2019 | $51,000 | +168.4% | 1,085 | +100.9% | 0.00% | – |
| Q1 2019 | $19,000 | +26.7% | 540 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | +87.5% | 540 | +182.7% | 0.00% | – |
| Q3 2018 | $8,000 | -27.3% | 191 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | – | 191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |